New Hope for HO: Tesomet is a new drug being trialed for Prader-Willi syndrome and Hypothalamic Obesity. Rami Levin describes the successful phase 2 trial results.

Interview of Saniona CEO, Rami Levin, about the results of the phase 2 trial of Tesomet.

This podcast features stories of patients and caregivers who serve as health advocates for themselves, family members or their rare disease community; conduct “citizen-scientist” literature reviews and research; and work (with or without research and clinical scientists) to discover their own treatment interventions for the difficult-to-treat conditions that often stump the medical establishment.

Dr. DIY host Eugenie Hsu is a clinical psychologist and citizen scientist, who has been a patient advocate on behalf of her son and believes in working to advance science for optimal quality-of-life.

Alternative Health

Health & Fitness

This podcast features stories of patients and caregivers who serve as health advocates for themselves, family members or their rare disease community; conduct “citizen-scientist” literature reviews and research; and work (with or without research and clinical scientists) to discover their own treatment interventions for the difficult-to-treat conditions that often stump the medical establishment. Dr. DIY host Eugenie Hsu is a clinical psychologist and citizen scientist, who has been a patient advocate on behalf of her son and believes in working to advance science for optimal quality-of-life.

Share Interview of Saniona CEO, Rami Levin, about the results of the phase 2 trial of Tesomet.

Sign up to save your podcasts

Interview of Saniona CEO, Rami Levin, about the results of the phase 2 trial of Tesomet.

Interview of Saniona CEO, Rami Levin, about the results of the phase 2 trial of Tesomet.